ADORA2A and epilepsy: Specifically, they enhance neuronal excitability by upregulating the adenosine A2A receptor and decreasing glutamate reuptake, thereby driving epilepsy progression and suggesting a new therapeutic target.[10] These findings highlight the critical role of the APOE gene in epilepsy progression.